Atlas Trials

The Effect of Rifaximin on Portal Vein Thrombosis

Clinical trial NCT03631147 · UNKNOWN

Trial details

NCT number
NCT03631147
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
CirrhosisPortal Vein Thrombosis
Start date
2018-09-03
Primary completion
2019-06-30
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.